Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammatory bowel disease: An audit

Volume: 39, Issue: 5, Pages: 426 - 434
Published: Oct 1, 2020
Abstract
Infliximab (IFX) monitoring has been proposed for effective therapeutic management of inflammatory bowel disease (IBD). There is no data on infliximab levels and its antibody measurement in Indian patients. We assessed the clinical efficacy of IFX level and antibodies to infliximab (ATI) monitoring in IBD patients. Infliximab trough level and antibody testing was done in 50 and 30 IBD patients, respectively using commercially available...
Paper Details
Title
Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammatory bowel disease: An audit
Published Date
Oct 1, 2020
Volume
39
Issue
5
Pages
426 - 434
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.